Stock data
Bicycle Therapeutics plc (BCYC)
Bicycle Therapeutics plc (BCYC) reported revenue of US$72.59M and net income of -US$218.96M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$72.59M | — | -US$247.06M | -US$218.96M | — |
| 2024 | US$35.27M | — | -US$209.87M | -US$169.03M | — |
| 2023 | US$26.98M | — | -US$189.95M | -US$180.66M | — |
| 2022 | US$14.46M | — | -US$116.65M | -US$112.72M | — |
| 2021 | US$11.70M | — | -US$65.62M | -US$66.82M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$0.63M | -US$50.33M | — |
| 2026-03-31 | US$0.89M | -US$60.83M | — |
| 2025-12-31 | US$47.95M | -US$20.15M | — |
| 2025-09-30 | US$11.73M | -US$59.10M | — |
| 2025-06-30 | US$2.92M | -US$78.95M | — |
| 2025-03-31 | US$9.98M | -US$60.75M | — |
| 2024-12-31 | US$3.71M | -US$51.85M | — |
| 2024-09-30 | US$2.68M | -US$50.80M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.